AHA Coding Clinic® for ICD-9 - 2009 Quarter 4; VOLUMES 1 & 2 NEW/REVISED CODES
Antineoplastic Chemotherapy Induced Anemia
A patient with metastatic, nonsmall cell lung cancer of the right upper lobe of the lung developed anemia following chemotherapy. The patient presents to the oncologist for follow-up and the oncologist listed anemia of chemotherapy in his diagnostic statement. What code should be assigned for the anemia? ...
Subscribe or sign in to view the full article.
Article Overview
This premium coding article discusses the ICD-9-CM addition for antineoplastic chemotherapy induced anemia and the need for greater specificity in reporting anemia related to cancer treatment. It also places the update in the context of nearby anemia categories, exclusions, and guidance references from official coding instructions. The content is aimed at coders, CDI professionals, and billing staff who need to understand how this topic was being distinguished in the ICD-9-CM era.
Why This Topic Matters
Accurate identification of chemotherapy-associated anemia affects coding specificity and reporting consistency. The article helps readers understand how the new diagnosis code fits into the broader anemia classification structure and related official guidance.
What You Will Learn
- How the ICD-9-CM classification was updated to distinguish anemia associated with antineoplastic chemotherapy
- How this topic relates to other anemia categories and exclusion notes
- Where to look in official coding guidance for further instruction
- The general reporting context for anemia arising during cancer treatment
Who Should Read This
- Medical coders
- Coding auditors
- CDI specialists
- Oncology billing staff
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com